Risk Breakdown
Financial Exposure
Governance
Double Materiality
Supply Chain
Material Risks
ESG Targets & Commitments
| Topic | Target / Metric | Status |
|---|---|---|
| Human Rights in Supply Chain | HR clauses in all contracts | Commitment |
AI Risk Summary
**Financial Risk Summary: Metropolis Healthcare Limited** Metropolis faces critical compliance exposure with an estimated financial liability of ₹195–730 crore due to incomplete ESG disclosure and governance gaps under SEBI BRSR Core Expansion requirements, creating material delisting and enforcement action risk for a top-tier listed company. EPR (Extended Producer Responsibility) applicability remains unresolved despite a 6.5/10 exposure rating; clarification is urgent as diagnostic waste streams (sharps, biohazardous materials) may trigger CPCB/state-level EPR obligations under the Plastic Waste Management Rules 2021, adding unforeseen operational costs. With a 10.0/10 compliance risk score and non-disclosure of Scope 1 and 2 emissions despite high-revenue operations (₹121,654.3 crore), the company risks SEBI enforcement action, stock exchange scrutiny, and potential delisting if BRSR disclosure gaps persist through the next regulatory cycle. Immediate priority: quantify and disclose scope emissions, map EPR applicability, and close governance documentation gaps to mitigate
Source: Metropolis Healthcare Limited BRSR Filing, FY -. Derived from the company's own public disclosures. Not investment advice or a regulatory determination.